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ATR (ATMandRad3-related) initiates aDNAdamage signal-
ing pathway in human cells upon DNA damage induced by UV
and UV-mimetic agents and in response to inhibition of DNA
replication. Genetic datawith human cells and in vitro datawith
Xenopus egg extracts have led to the conclusion that the kinase
activity of ATR toward the signal-transducing kinase Chk1
depends on the mediator protein Claspin. Here we have recon-
stituted a Claspin-mediated checkpoint system with purified
human proteins. We find that the ATR-dependent phosphoryla-
tion of Chk1, but not p53, is strongly stimulated by Claspin.
Similarly, DNA containing bulky base adducts stimulates ATR
kinase activity, and Claspin acts synergistically with damaged
DNAto increase phosphorylation ofChk1byATR.Mutations in
putative phosphorylation sites in the Chk1-binding domain of
Claspin abolish its ability to mediate ATR phosphorylation of
Chk1. We also find that a fragment of Claspin containing the
Chk1-binding domain together with a domain conserved in the
yeast Mrc1 orthologs of Claspin is sufficient for its mediator
activity. This in vitro system recapitulates essential components
of the genetically defined ATR-signaling pathway.
DNA damage checkpoints delay cell cycle progression in
response to DNA damage to maintain genomic integrity. In
mammalian cells, two major signaling pathways that mediate
the checkpoint response have been described: the ATM2 3
Chk2 pathway that is activated mainly, but not exclusively, by
double-strand breaks and the ATR 3 Chk1 pathway that is
primarily activated by UV and UV-mimetic chemical agents as
well as replication fork stalling due to DNA damage or nucleo-
tide depletion (1). Upon activation, ATR phosphorylates Chk1
on Ser317 and Ser345 (2, 3) in a manner dependent on the medi-
ator protein Claspin (4–6). Claspin was originally identified
as a Chk1-interacting protein in Xenopus laevis egg extracts,
where it was shown to be indispensable for ATR-dependent
phosphorylation of Chk1 (7). Subsequent studies identified a
57-amino acid minimal Chk1-binding domain (CKBD) of
Xenopus Claspin (8). Mutations in this domain abrogate
Claspin-Chk1 association as well as the phosphorylation of
Chk1 by ATR in both Xenopus (8–10) and human systems
(11, 12).
Genetic studies in human cell lines and in vitro studies with
HeLa cell-free extracts and Xenopus egg extracts have identi-
fied many proteins including RPA, the ATR-ATRIP het-
erodimer, the Rad17-RFC9-1-1 and TimelessTipin check-
point complexes, TopBP1, andClaspin as essential components
for phosphorylation ofChk1 and activating theDNAdamage or
replication checkpoints (1). It was found that under certain
reaction conditions, TopBP1 alone was sufficient to promote
phosphorylation ofChk1 byATR (13). Recently, using a defined
system, we found that under physiologically relevant ionic
strength, Chk1 phosphorylation by ATR was both TopBP1-de-
pendent and DNA-dependent (14, 15). The ATR3 Chk1 sig-
naling pathway in these in vitro studies was not dependent on
the other checkpoint proteins known to be required for ATR
activation. A fully reconstituted checkpoint system that incor-
porates all of the genetically defined components would greatly
facilitate mechanistic studies of this important DNA damage
response pathway. In the current study, we have analyzed the
contribution of Claspin to phosphorylation of Chk1 by ATR.
We find that Claspin strongly stimulates the TopBP1-depen-
dent ATR phosphorylation of Chk1 but not phosphorylation of
otherATR substrates such as p53, and this stimulation is ampli-
fied by damaged DNA. Claspin functions by increasing the
affinity ofATR forChk1, andmutations in theCKBDofClaspin
abrogate its mediator activity.We have identified a fragment of
Claspin that contains the CKBD together with a domain con-
served in the Mrc1 yeast orthologs of Claspin that is sufficient
to stimulate ATR phosphorylation of Chk1. Our minimal
checkpoint system provides a useful platform for analyzing the
function of the Claspin mediator in the ATR-signaling
pathway.
EXPERIMENTAL PROCEDURES
Antibodies and DNA—Chk1 phospho-Ser345 and p53 phos-
pho-Ser15 antibodieswere purchased fromCell SignalingTech-
nology (Danvers, MA). Chk1, p53, and GST antibodies were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA),
and FLAGM2 antibodies were from Sigma. A 2-kb linear DNA
fragment modified with Benzo[a]pyrene diol epoxide (BPDE)
was prepared as described previously (15, 16). Both single-
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stranded and double-stranded undamagedDNAs stimulate the
reaction (14–16); however, because the stimulation of ATR
kinase was much stronger, we carried out all our experiments
with BPDE-DNA in this study.
Purification of Checkpoint Proteins—Native ATR-ATRIP,
GST-TopBP1-His, GST-TopBP1-C fragment, GST-p53, His-
Chk1 kinase dead (Chk1-kd), and FLAG-tagged full-length
Claspin and Claspin 851 were all purified as described previ-
ously (14–17). Point mutations were produced in Claspin by
site-directed mutagenesis according to the QuikChange
instructions (Stratagene). GST-tagged fragments of Claspin
were generated by subcloning into pGEX-4T1 (GEHealthcare)
and purification from Escherichia coliwith glutathione agarose
according to the manufacturer’s instructions.
Kinase Assays—The procedure was similar to our previously
described system (16). Briefly, kinase assay reactions contained
12 mM Hepes, pH 7.9, 1.2 mM MgCl2, 0.4 mM ATP, 0.3 mM
dithiothreitol, 0.6% polyethylene glycol 6000, 35 mM KCl, 25
ng/l bovine serum albumin, and 1 M microcystin in a 10-l
final volume. Unless otherwise indicated, 0.25 nM purified
ATR-ATRIP was incubated for 15 min at 30 °C with 0.5 nM
recombinant full-lengthTopBP1orTopBP1-C fragment, 10 nM
Chk1-kd or p53, with the indicated concentrations of Claspin
orDNA.The reactionswere terminated by the addition of SDS-
PAGE loading buffer and separated by 10% SDS-PAGE. Chk1
or p53 phosphorylation was detected by immunoblotting using
the indicated phospho-specific antibodies, and the levels of
total Chk1 and p53 proteins were subsequently detected by
immunoblotting the same membrane. Levels of phosphoryla-
tion were quantified using the ImageQuant 5.2 software after
scanning the immunoblots. The highest level of Chk1 phosphor-
ylation in each experiment was set equal to 100, and the levels of
phosphorylated Chk1 in the other lanes were determined relative
to this value, except inFig. 1,where thephosphorylation in the first
(control) lane was set equal to 1 to facilitate the comparison
between p53 andChk1. The averages from at least three indepen-
dent experiments were graphed, and the error bars indicate the
average deviation from themean (see Figs. 1–5).
In the experiments with [-32P]ATP, 20 Ci of radiolabel
was included in the kinase reactions, and the final concentra-
tions of ATP and bovine serum albumin were lowered to 0.1
mM and 10 ng/l, respectively. After separation on SDS-PAGE,
the proteins were silver-stained, and then the gel was dried and
analyzed by phosphorimaging. For quantification purposes, a
phosphate standard curve was generated by spotting dilutions
of the kinase mixture. The amount of Pi incorporated into
Claspin or Chk1 was divided by the known amount of protein
included in the reactionmixture to obtain the number of phos-
phates incorporated into each Claspin or Chk1 molecule. The
averages from three independent experiments were graphed,
and the error bars indicate the average deviation from themean
(see Fig. 5D).
RESULTS
Claspin Specifically Stimulates ATR Kinase Activity Toward
Chk1—It has been reported that ATR phosphorylation of Chk1
on Ser345, but not phosphorylation of other ATR substrates,
such as p53, is dependent on Claspin in vivo (6). Having
obtained the requisite proteins in highly purified forms, we set
out to test this model in a defined system. Because it has been
shown that under certain reaction conditions TopBP1 is suffi-
cient to activate ATR kinase on the Chk1 substrate (13, 14), we
used this platform to test the contribution of Claspin to the
phosphorylation of either Ser345 of Chk1 or Ser15 of p53 by
ATR. The results from such an experiment are shown in Fig.
1A. Claspin significantly stimulates the kinase activity of ATR
toward Chk1 (lanes 3–6 versus lane 1) but not p53 (lanes 9–12
versus lane 7). Similarly, DNA containing bulky adducts stim-
ulates the TopBP1-dependent phosphorylation of both Chk1
(lane 2) and p53 (lane 8) by ATR, consistent with our previous
reports (14–16). Thus, although damaged DNA stimulates
ATRkinase activity on either substrate, the stimulatory effect of
Claspin is specific for Chk1.
Analysis of the in Vitro Requirements for Claspin-mediated
Chk1 Phosphorylation—We next tested the optimal require-
ment and specificity for two essential components, ATR-
ATRIP and TopBP1, in the Claspin-dependent kinase reac-
tions. The results shown in Fig. 1B indicate that the
phosphorylation of Chk1 is completely dependent on ATR-
ATRIP (lanes 1 and 7), and increasing theATR-ATRIP concen-
tration in the kinase reactions resulted in a corresponding
increase of Chk1 phosphorylation (lanes 2–6). Importantly,
there was up to 10-fold more phosphorylation of Chk1 when
Claspin was included in the reaction mixture (lanes 8–12).
We have previously shown that the ATR kinase activity in
our in vitro system is dependent on TopBP1 (14) and that a
carboxyl-terminal (C) fragment of TopBP1 is sufficient for con-
ferring damagedDNA-dependent stimulation of ATR (15).We
wished to determine whether the Claspin-dependent stimula-
tion of Chk1 phosphorylation by ATR is also dependent on
TopBP1 and whether the C-fragment is sufficient. In Fig. 1C,
increasing amounts of Claspin were added to reactions lacking
TopBP1 (lanes 1–4) or containing full-length (FL) TopBP1
(lanes 5–8) or the C-fragment of TopBP1 (lanes 9–12). Even at
the highest concentration of Claspin, no Chk1 phosphorylation
is detectable in reactions lacking TopBP1 (lane 4), indicating
that Claspin alone is not sufficient. However, ATR phosphor-
ylates Chk1 in reactions containing either the full length
TopBP1 or the C-fragment of TopBP1, and under these condi-
tions, the phosphorylation is completely dependent on Claspin
(compare lanes 5 and 8 with lanes 9 and 12). This experiment,
for the first time, reconstitutes a TopBP1-dependent and
Claspin-dependent in vitro ATR3 Chk1 signaling system.
Mechanistic Details of Claspin-dependent Phosphorylation of
Chk1—Next, we wished to analyze the mechanism by which
Claspin stimulates the ATR kinase inmore detail. First, we per-
formed ATR kinase reactions under conditions of increasing
ionic strength (Fig. 2A). As we have previously reported, the
TopBP1-mediated ATR kinase activity is highly sensitive to the
ionic strength of the reaction (lanes 1–8) (14). We find that
the stimulatory effect of Claspin is also sensitive to the ionic
strength (lanes 9–16), with the 2-fold difference in the slopes of
the lines of TopBP1- and TopBP1Claspin-stimulated kinase
activity, indicating that the Claspin-dependent stimulation of
ATR is twice as sensitive. This sensitivity to ionic strength is
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likely due to salt-sensitive protein-protein interactions of
Claspin required to mediate the kinase reaction.
The results from kinetic experiments indicate that Claspin
increases the initial rate of the kinase reaction by 5-fold (Fig.
2B). To better understand the mechanistic basis of the effect of
Claspin in the reaction, we conducted the experiment shown in
Fig. 2C in which the rate of Chk1 phosphorylation was mea-
sured as a function of Chk1 concentration in ATR kinase reac-
tions lacking Claspin (lanes 1–6) or containing Claspin (lanes
7–12). Analysis of these data by the Lineweaver-Burk plot (18)
enabled us to estimate theVmax andKm for the kinase reactions
with Chk1 substrate and the effects of Claspin on the kinetic
parameters.We find that there is less than a 2-fold difference in
Vmax for reactions containing Claspin (91 fmol of Pi/min)
than for reactions lacking Claspin (57 fmol of Pi/min). How-
ever, the Km is decreased 17-fold by Claspin (Km  7 nM with
Claspin;Km  120 without Claspin). Although this ATR kinase
reaction is relatively complex because of the requirement for
multiple protein-protein interactions, the large change in the
Km indicates that the stimulation of Chk1 phosphorylation
observed in the presence of Claspin is primarily achieved by
increasing the affinity of ATR for Chk1.
Mutations in the CKBD of Claspin Abolish Its Mediator
Activity—In vivo studies have suggested that the phosphoryla-
tions of Thr916, Ser945, and Ser982 in the CKBD of Claspin are
important for Chk1 phosphorylation by ATR during the check-
point response toDNAdamage or stalled replication forks (12).
We wished to test this observation in our in vitro system to
ascertain the validity of this system and possibly gain insight
into the role of Claspin phosphorylation in the checkpoint
response. To this end, we used wild-type Claspin, Claspin car-
rying Thr/Ser 3 Ala mutations at the phosphorylation sites
(3A), or the Thr/Ser 3 Asp phosphomimetic replacements
(3D) at these sites in our in vitro assay. All three proteins were
made in the baculovirus/insect cell expression systems. When
the three proteins were tested in our assay, the wild-type (WT)
Claspin stimulated the TopBP1-dependent phosphorylation of
Chk1 up to 10-fold, whereas the mutants had only modest or
no effect (Fig. 3). These results further support the notion that
FIGURE 1. Claspin specifically stimulates TopBP1-dependent ATR phos-
phorylation of Chk1 in a defined system. A, Claspin specifically stimulates
ATR phosphorylation of Chk1 but not p53. All reactions contain 0.25 nM ATR
and 0.5 nM TopBP1. Reactions 1– 6 contain 10 nM His-Chk1kd, and reactions
7–12 contain 10 nM GST-p53. 1 ng of BPDE-modified 2-kb linear DNA was
added to reactions in lanes 2 and 8. The values in lanes 1 and 7 are normalized
to 1. ATR kinase activity was determined by immunoblotting for phospho-
Chk1 (-P-Chk1), Chk1, phospho-p53 (-P-p53), and p53 as indicated. The
graph shows quantitative analysis of the data from three independent exper-
iments conducted under identical conditions. DNA stimulates both Chk1 and
p53 phosphorylation, whereas Claspin stimulates Chk1 but not p53 phosphor-
ylation. Values that are statistically different (T value 0.03 in the paired t test)
than the control reactions (lanes 1 or 7) are indicated with an asterisk. The error
bars indicate the average deviation from the mean. B, Claspin-mediated
phosphorylation of Chk1 is dependent on ATR. 0, 0.125, 0.25, 0.5, 1, and 2 nM
purified ATR-ATRIP was added to reactions lacking Claspin (lanes 1– 6) or con-
taining 16 nM Claspin (lanes 7–12) in addition to 0.5 nM TopBP1 and 10 nM
Chk1kd. The results from three experiments were quantified and plotted. 0.25
nM ATR-ATRIP was chosen for the later kinase reactions. C, ATR activation by
Claspin is dependent on TopBP1, and the C-terminal fragment of TopBP1 is
sufficient. Kinase reactions containing 0, 2, 6, or 18 nM Claspin were per-
formed without TopBP1 (lanes 1– 4), with 1 nM full-length TopBP1 (FL) (lanes
5– 8), or with 1 nM of the TopBP1-C fragment (C) (lanes 9 –12).
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our in vitro system is a faithful representation of the in vivo
ATR3 Chk1 signaling pathway.
ATR Phosphorylation of Chk1 Is Stimulated by the C Ter-
minus of Claspin and Is Further Stimulated by Damaged
DNA—We have previously reported that Claspin is a DNA-
binding protein and identified DNA-binding domains in
fragments encompassing the N- and C-terminal halves of the
protein (17). We examined the effects of these fragments on
Chk1 phosphorylation by ATR to better define the role of
Claspin in mediating ATR kinase activity. As seen in Fig. 4A,
either full-length (FL) Claspin (lanes 2–6) or a C-terminal
fragment of Claspin (851) (lanes 8–12), which contains the
CKBD, stimulates ATR phosphorylation of Chk1 up to
10-fold, and the C-terminal fragment appears to be more
active than full-length Claspin, under these experimental
conditions, suggesting that the
N-terminal domain of Claspin
may serve as a regulator of the
reaction. Because this fragment
has DNA binding activity (17), and
we have previously shown that
DNA stimulates the kinase activity
of ATR in the presence of TopBP1
(14, 15), we wished to test the
effect of adding both Claspin and
DNA to the kinase reaction. The
results are shown in Fig. 4B. Under
these conditions, the addition of
either damaged DNA (lane 2) or
Claspin (lane 3) results in 4-fold
more phosphorylation of Chk1
when compared with the control
reaction (lane 1). However, the
addition of both DNA and Claspin
to the reaction (lane 4) resulted in
20-fold more phosphorylation
than the control reaction, which
suggests synergy of DNA and
Claspin in stimulating ATR kinase
because the stimulation is more
than 2-fold higher than the sum of
the kinase activity with either
DNA alone or Claspin alone.
Identification of a Minimal Func-
tional Domain of Claspin—To more
precisely define the region of
Claspin sufficient to mediate ATR
phosphorylation of Chk1 in our sys-
tem, we generated the fragments of
Claspin summarized in Fig. 5A.
Fragments spanning theN-terminal
half (N) and C-terminal half (C) of
Claspin were purified from E. coli
and tested in the ATR kinase assay
(Fig. 5B). The addition of the C-ter-
minal half of Claspin resulted in
10-fold stimulation of ATR phos-
phorylation of Chk1 (compare lanes
4 and 5with lane 1), whereas the N-terminal half of Claspin did
not have a significant effect on ATR kinase activity (lanes 2 and
3). We further truncated the C-fragment, and discovered that
the middle (M) region (lanes 6 and 7) was as active as the
C-fragment. However, further deletions from the N or C ter-
mini of theM fragment (MN, lanes 8 and 9, andMC, lanes 10
and 11) abolish the stimulatory effect. Therefore, we conclude
that the 354 amino acids between amino acid 852 and 1206 are
sufficient for Claspin to mediate Chk1 phosphorylation by
ATR.
To confirm our findings that mutations of the putative phos-
phorylation sites in the CKBD of full-length Claspin abrogate
its function (Fig. 3), we also tested the effect of changing amino
acids 916, 945, and 982 to alanine (3A) in theClaspin fragments.
The results are shown in Fig. 5C. Mutating the putative phos-
FIGURE 2. Claspin mediates the phosphorylation of Chk1 by ATR through a salt-sensitive mechanism
that increases the affinity of ATR for Chk1. A, Claspin stimulation of ATR phosphorylation of Chk1 is sensitive
to ionic strength. Kinase assays were carried out with ATR-ATRIP (0.25 nM), Chk1 (10 nM), and TopBP1-C (0.5 nM)
under different ionic strength conditions (35–105 mM KCl) in the absence or presence of 16 nM Claspin. The
error bars indicate the average deviation from the mean. -P-Chk1, phospho-Chk1; -P-Chk1-p53, phospho-
p53. B, kinetics of Claspin stimulation of phosphorylation of Chk1 by ATR. Kinase assays were performed as
described in the legend for Fig. 1 with 10 nM His-Chk1 and incubated for the indicated amount of time without
Claspin or with 16 nM Claspin. C, Claspin affects the affinity of ATR for Chk1. Kinase assays were performed as
described in B, except that the Chk1 concentration varied from 0 to 50 nM. The results from three experiments
were quantified and plotted as before (top graph) or with the Lineweaver-Burk format of 1/v versus 1/[S]
(bottom graph), which allows for calculating the Km  1/x-intercept and the Vmax  1/y-intercept. The equa-
tion for the lines fitting the data for reactions lacking Claspin is y  2.1049x  0.0175, and for reactions
containing Claspin, it is y  0.0784x  0.011. The units for Vmax have been determined by standardizing the
signal from Western blotting to the amount of Pi incorporated in experiments containing radioactive
[-32P]ATP. v, velocity.
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phorylation sites abolishes the ability of either Claspin frag-
ment C (compare lanes 4–6 with lanes 2 and 3) or Claspin
fragment M (compare lanes 9–11 with lanes 7 and 8) to stim-
ulate phosphorylation of Chk1 by ATR, consistent with the
results obtained with the full-length protein produced in insect
cells. Because these mutated residues are putative phosphoryla-
tion sites, and the bacterially produced protein is not phosphor-
ylated, we wished to measure the amount of phosphorylation
that occurs at these sites during the kinase reaction. We added
radiolabeled ATP to the kinase reactions shown in Fig. 5D and
quantified the amount of Pi incorporated in Claspin and Chk1.
The addition of wild-type Claspin M-fragment to the kinase
reaction containing Chk1-kd, TopBP1, and ATR-ATRIP (lane
8) resulted in 10- or 4-fold more Chk1 phosphorylation as
determined by Western analysis of Ser345 phosphorylation or
radioactive analysis of total Chk1 phosphorylation, respec-
tively, than in the equivalent reactions lacking Claspin (lane 3)
or containing Claspin with the 3A mutation (lane 13). In the
presence of ATR-ATRIP, 0.001 Pi was incorporated per
Claspin molecule. This was mediated by ATR-ATRIP because
there was no measurable radioactivity incorporated into wild-
type (WT) Claspin (lane 9) or 3A mutant (lane 14) in the
absence of ATR-ATRIP, and about 4-fold more was incorpo-
rated when TopBP1 was also added to the reaction (lanes 6 and
11). These results indicate that Claspin is phosphorylated by
ATR under these reaction conditions, however very ineffi-
ciently. Importantly, the amount of Claspin phosphorylation is
not affected when the putative phosphorylation sites are
mutated to alanine (compare lanes 5–8 with lanes 10–13),
indicating that the three Ser/Thr residues (which do not match
the ATR phosphorylation consensus sequence) involved in
Claspin-mediated Chk1 phosphorylation are not phosphoryla-
ted in this system.
DISCUSSION
Development of a Human Reconstituted Checkpoint Sys-
tem—The genetically defined minimal set of components
required for activation of the ATR3 Chk1 pathway of check-
point signaling in humans includes DNA, RPA, ATR-ATRIP,
TopBP1, Rad17-RFC9-1-1, TimelessTipin, Claspin, andChk1.
We previously described a minimal human in vitro checkpoint
system consisting of damaged DNA, TopBP1, ATR-ATRIP,
and Chk1 (14, 15). In this study, we have further developed the
system to recapitulate essential components of the genetically
FIGURE 3. Claspin-mediated ATR activation is dependent on the putative
phosphorylation sites in the Chk1-binding domain of Claspin. Kinase
assays were carried out with ATR-ATRIP, HisChk1-kd, and TopBP1-C fragment
as described in the legend for Fig. 2 except with 35 mM KCl and with 0, 1.5, 3,
6, or 12 nM Claspin wild type (WT) or Thr916, Ser945, and Ser982 mutated to
alanine (3A) or aspartic acid (3D). The graph shows quantitative analysis of the
data from five independent experiments conducted under identical condi-
tions. The error bars indicate the average deviation from the mean. -P-Chk1,
phospho-Chk1.
FIGURE 4. The C terminus of Claspin is sufficient to stimulate Chk1 phos-
phorylation by ATR and acts synergistically with damaged DNA. A, the C
terminus of Claspin is sufficient for stimulation of ATR phosphorylation of
Chk1. Kinase assays were carried out with ATR-ATRIP, HisChk1-kd, and
TopBP1 as described in the legend for Fig. 1 except with 0, 1, 2, 4, 8, or 16 nM
full-length (FL) Claspin or Claspin 851 fragment. The error bars indicate the
average deviation from the mean. -P-Chk1, phospho-Chk1. B, Claspin and
DNA synergistically stimulate ATR Kinase. Kinase assays were carried out with
ATR-ATRIP, HisChk1-kd, and TopBP1-C fragment as described in A except
with 75 mM KCl and with or without 16 nM Claspin 851 and 2 ng of
BPDE-damaged DNA.
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defined ATR-signaling pathway by incorporating Claspin. We
find that the combination of TopBP1 with Claspin is sufficient
to strongly stimulate the phosphorylation of Chk1 by ATR and
that damaged DNA further stimulates the phosphorylation
(Fig. 6).
Several studies in which HeLa cell-free extracts were used to
analyze ATR kinase activity have been reported (11, 19, 20).
Although these studies have been valuable, the presence of
other kinases in the extracts makes the results open to alterna-
tive interpretations and limits their usefulness. Therefore, we
have focused on developing a defined ATR checkpoint system
with purified proteins. Partially reconstituted ATR checkpoint
systems have been described in other species, including X. lae-
vis (13, 21, 22) and Saccharomyces cerevisiae (23–27). A bona
fide in vitro checkpoint system should depend on all of the
checkpoint proteins necessary for Chk1 phosphorylation as
defined by genetic data. By these criteria, our in vitro system
falls short of representing the human in vivo checkpoint path-
way. However, as it is often encountered in biochemical assays,
by employing special reaction conditions such as high enzyme
concentrations or non-physiological bivalent cations such as
Mn2 instead of Mg2, the in vitro reactions circumvent some
of the requirements for the reaction in vivo. Such systems nev-
ertheless do contribute to the understanding of the biochemical
function in question and to the ultimate development of in vitro
systems that by all criteria recapitulate the in vivo reaction.
From that perspective, our study may be considered a signifi-
cant advance over the previouswork aimed at establishing an in
vitro checkpoint system. We are able to stimulate the ATR
kinase phosphorylation of Chk1 by checkpoint components
known to be required: DNA, TopBP1, and Claspin.
In Vitro Systems with Xenopus Claspin—Claspin was origi-
nally discovered in Xenopus egg extracts (7) and was shown to
be indispensable for ATR-dependent phosphorylation of Chk1
in response to stalled DNA replication forks in cell-free reac-
tions (7, 22). Reconstitution of a Claspin-dependent reaction
with purifiedXenopus components has been attempted (21, 22)
but appears to be complicated by the requirement for Claspin
to be phosphorylated (8, 10, 21). Mutations of two serines
(Ser864 and Ser895) inXenopusClaspin, which have been shown
to be phosphorylated during the checkpoint response (8), abro-
gate its ability to interact with Chk1 (8, 10, 28) and to mediate
Chk1 phosphorylation by ATR in egg extracts (8). These two
serines are located in highly conserved repeats of about 10
amino acids in the CKBD of Claspin. Human Claspin contains
three of these conserved repeats, and our results suggest that
although mutations of the equivalent putative phosphorylated
residues (Thr916, Ser945, and Ser982) abrogate the mediator
function of Claspin (Figs. 3 and 5C), the residues are not phos-
phorylated in our system (Fig. 5D). Phospho-specific antibodies
have been used to demonstrate that Thr916 is phosphorylated in
human cell lines after DNA damage (12, 29, 30), and because
the 3A mutation abolishes the ability of human Claspin to
mediate Chk1 phosphorylation (12), it was concluded that
phosphorylation of these sites is required for Claspin function.
The results from our reconstituted system raise some doubt
about this conclusion and suggest that it is the mutations, not
the phosphorylation states of the Ser/Thr residues, that disrupt
the mediator function of Claspin. In fact, phosphomimetic
mutations at these amino acids abolish function in our system
FIGURE 5. Identification of the minimal functional domain in Claspin. A, schematic of the Claspin fragments and summary of their ability to mediate Chk1
phosphorylation by ATR. The locations of the putative phosphorylation site mutations at Thr916, Ser945, and Ser982 (3A and 3D) in the CKBD are indicated. The
Mrc1-like domain (MRC1, amino acids 1045–1203) is defined in the Pfam protein families data base as a putative domain of average length of 142.3 amino acids
that is found to be the most conserved region in Mrc1 (31). B, stimulation of ATR phosphorylation of Chk1 by Claspin fragments. Kinase assays were carried out
with ATR-ATRIP, HisChk1-kd, and TopBP1 as described in the legend for Fig. 1 except with 0, 3, or 30 nM of the indicated Claspin fragment. The error bars indicate
the average deviation from the mean. -P-Chk1, phospho-Chk1. C, mutations in the Chk1-binding domain of the Claspin fragments abolish their ability to
stimulate ATR phosphorylation of Chk1. Kinase assays were carried out with ATR-ATRIP, HisChk1-kd, and TopBP1 as described in B except with 0, 3, 30, or 300
nM of the indicated Claspin fragment. D, kinase assays were carried out with ATR-ATRIP, Chk1-kd, and TopBP1 as described in the legend for Fig. 1 except with
the addition of [-32P]ATP to monitor the total phosphorylation in the reaction. 25 nM wild-type (WT) Claspin-M fragment or the Claspin-M fragment containing
alanine mutations in the putative phosphorylation sites (3A) were included into the reactions as indicated. Half of the kinase reaction was loaded onto a gel for
analysis by immunoblotting for phospho-Chk1 and Chk1, and the other half of the reaction was loaded onto a separate gel for analysis by silver staining and
phosphorimaging as indicated. BSA, bovine serum albumin.
FIGURE 6. Model for Claspin-mediated Phosphorylation of Chk1 by ATR.
ATR-ATRIP may be recruited to DNA by several mechanisms, all of which
eventually lead to enhanced kinase activity. Thus, TopBP1 recruits ATR-ATRIP
to DNA containing bulky adducts (indicated by the triangle). Claspin binds to
both DNA and Chk1 and increases the affinity of ATR for Chk1 through a
mechanism that requires the Chk1-binding domain and the MRC1-like
domain. Note that this is one mechanism by which ATR and its co-activators
can be recruited to DNA. There are alternative pathways of recruiting ATR
such as by RPA, mismatch repair proteins, and other factors. The circled P
indicates phosphorylation.
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(Fig. 3) and in Xenopus egg extracts (8). The identity of the
kinase that phosphorylates Claspin on these residues is
unknown. These sites do not match the ATR consensus
sequence ((S/T)Q), but ATR appears to be required to activate
the kinase that phosphorylates these residues (8). An initial
report implicated Chk1 (12); however, this was subsequently
disputed (30). We conducted the experiments in this report
with kinase-inactive Chk1 to avoid this complication.However,
we did not detect a difference in the Claspin-dependent activa-
tion of ATR in reactions containing wild-type Chk1 (data not
shown), suggesting that if there is significant phosphorylation
of these sites by Chk1, it does not significantly affect Claspin
function in our assay. Ultimately, our system will be useful for
evaluating the functional significance of Claspin phosphoryla-
tion after identification of the kinase.
In Vitro Systemwith Yeast Proteins—Using purified proteins,
it was recently reported that the budding yeast Claspin
ortholog, Mrc1, stimulates phosphorylation of the Chk1 func-
tional ortholog, Rad53, by theMec1 kinase (ATR ortholog) in a
manner similar to our findings (26). However, in contrast to our
system in which Claspin-dependent ATR phosphorylation of
Chk1 is dependent on the presence of TopBP1 (Fig. 1C), the
yeastMrc1Claspin-dependent checkpoint systemdid not require
the addition of the yeast TopBP1 homolog, Dpb11 (26). Simi-
larly, the Rad17-RFC/9-1-1-dependent yeast Mec1ATR check-
point system did not depend on the presence of Dpb11TopBP1
(25), although it was later reported that Dpb11TopBP1 acted syn-
ergistically with Rad17-RFC/9-1-1 in that system (24). We fur-
ther demonstrated that the C terminus of TopBP1 is sufficient
for Claspin-dependent stimulation of Chk1 phosphorylation by
ATR. This fragment of TopBP1 is also sufficient to confer the
damaged DNA-dependent stimulation of ATR, and in fact,
damaged DNA acts synergistically with Claspin in our system
(Fig. 4B).
Conclusion—Our minimal checkpoint system is the closest
approximation to the genetically defined human ATR3 Chk1
signaling pathway in that it incorporates ATR-ATRIP, Chk1,
TopBP1, DNA, and Claspin for optimal ATR kinase activity on
Chk1. As such, we believe this systemwill provide a useful plat-
form for analyzing the contribution of the other components
known to be required in the ATR-signaling pathway and ulti-
mately defining the roles of the individual components by
experimental designs addressing specific questions in a readily
controllable in vitro system.However, with current technology,
it is not possible to evaluate the spatio-temporal factors that
play an important role in the cellular response to the complex-
ity of DNA damage in the nucleus and its effect on cell-cycle
progression.
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